The difference between imported Dasatinib and domestically produced one

Imported dasatinib (Dasatinib) and domestic dasatinib may be slightly different in appearance, manufacturer, price, etc., such as color, shape and packaging. Imported dasatinib is usually produced by foreign pharmaceutical companies, and the original research manufacturers include Bristol-Myers Squibb Company, while domestic dasatinib is produced by domestic pharmaceutical companies, such as Chia Tai Tianqing Pharmaceutical Co., Ltd., BeiGene Pharmaceutical Co., Ltd., etc.

Dasatinib is an important anticancer drug used to treat chronic myelogenous leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL). Imported medicines usually undergo stricter quality control and supervision to ensure compliance with international standards. Domestic drugs also need to meet the quality requirements of relevant national regulations, but regulatory standards may be different.

Imported pharmaceuticals typically cost more, which may be due to import shipping costs, intellectual property fees, and other factors. In contrast, domestically produced drugs may be more affordable. Dasatinib has been launched in China and is included in the scope of Class B medical insurance. Reimbursement is limited to eligible patients. The common specifications of imported drugsThe price of 50mg*60 tablets per box may be around 10,000 yuan, and the common price of domestic drugs of 50mg*7 tablets per box may be several hundred yuan.

The original drug of dasatinib currently sold overseas is more expensive. Generic drugs of dasatinib are also sold overseas. The drug ingredients are basically the same as those sold domestically and abroad, but the price is cheap. For example, the price of a box of 50mg*60 tablets produced by an Indian pharmaceutical factory may be several hundred yuan (the price may fluctuate due to exchange rates).